Furthermore, osteoblasts and MSC-secreted CXCL12 were shown to interact with CXCR4 receptors of leukemia stem cells, activating survival and antiapoptotic signaling pathways, specifically MAPK and PIK3/Akt [146]. This evidence concerns the gene CXCL12 and leukemia.